162 related articles for article (PubMed ID: 30930982)
1. P21 activated kinase 2 promotes pancreatic cancer growth and metastasis.
Yao GW; Bai JR; Zhang DP
Oncol Lett; 2019 Apr; 17(4):3709-3718. PubMed ID: 30930982
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.
Cheng TY; Yang YC; Wang HP; Tien YW; Shun CT; Huang HY; Hsiao M; Hua KT
Oncogene; 2018 Mar; 37(13):1730-1742. PubMed ID: 29335522
[TBL] [Abstract][Full Text] [Related]
4. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
[TBL] [Abstract][Full Text] [Related]
5. PAK2 promotes proliferation, migration, and invasion of lung squamous cell carcinoma through LIMK1/cofilin signaling pathway.
Wang C; Wang J; Xu R; Huang X; Li Q; Zhang C; Yuan B
J Biomed Res; 2024 May; ():1-14. PubMed ID: 38828848
[TBL] [Abstract][Full Text] [Related]
6. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
7. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.
Gao C; Ma T; Pang L; Xie R
Diagn Pathol; 2014 Mar; 9():55. PubMed ID: 24621074
[TBL] [Abstract][Full Text] [Related]
8. PAK2 promotes migration and proliferation of salivary gland adenoid cystic carcinoma.
Deng WW; Wu L; Bu LL; Liu JF; Li YC; Ma SR; Yu GT; Mao L; Zhang WF; Sun ZJ
Am J Transl Res; 2016; 8(8):3387-97. PubMed ID: 27648129
[TBL] [Abstract][Full Text] [Related]
9. MOB1 Inhibits Malignant Progression of Colorectal Cancer by Targeting PAK2.
Liu J; Shi Z; Ma Y; Fu L; Yi M
Onco Targets Ther; 2020; 13():8803-8811. PubMed ID: 32943885
[TBL] [Abstract][Full Text] [Related]
10. LINC00858 promotes colorectal cancer by sponging miR-4766-5p to regulate PAK2.
Zhan W; Liao X; Chen Z; Li L; Tian T; Yu L; Li R
Cell Biol Toxicol; 2020 Aug; 36(4):333-347. PubMed ID: 31902050
[TBL] [Abstract][Full Text] [Related]
11. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
[TBL] [Abstract][Full Text] [Related]
12. miR-511-5p Suppresses Cell Migration, Invasion and Epithelial-Mesenchymal Transition Through Targeting PAK2 in Gastric Cancer.
Yong W; Zhang K; Deng Y; Tang W; Tao R
Biochem Genet; 2022 Jun; 60(3):899-913. PubMed ID: 34542739
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.
Nuche-Berenguer B; Jensen RT
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2371-82. PubMed ID: 25979836
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA 0001789 sponges miR-140-3p and regulates PAK2 to promote the progression of gastric cancer.
You J; Chen Y; Chen D; Li Y; Wang T; Zhu J; Hong Q; Li Q
J Transl Med; 2023 Feb; 21(1):83. PubMed ID: 36740679
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
17. P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer.
Yi Y; Li P; Huang Y; Chen D; Fan S; Wang J; Yang M; Zeng S; Deng J; Lv X; Luo K; He Z; Liu H
Oncogene; 2022 Sep; 41(37):4318-4329. PubMed ID: 35986102
[TBL] [Abstract][Full Text] [Related]
18. Motility of select ovarian cancer cell lines: effect of extra-cellular matrix proteins and the involvement of PAK2.
Flate E; Stalvey JR
Int J Oncol; 2014 Oct; 45(4):1401-11. PubMed ID: 25050916
[TBL] [Abstract][Full Text] [Related]
19. Specificity protein 1-activated bone marrow stromal cell antigen 2 accelerates pancreatic cancer cell proliferation and migration.
Lei C; Hou Y; Chen J
Exp Ther Med; 2021 Dec; 22(6):1459. PubMed ID: 34737799
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
